Prenatal exposures associated with neurodevelopmental delay and disabilities

Developmental Disabilities Research Reviews

Volumn 17, Issue 2, 2011, Pages 71-84

  Diav Citrin, Orna ^a,b  

^a MINISTRY OF HEALTH   (Israel)

^b HEBREW UNIVERSITY   (Israel)

Author keywords

Antiepileptic drugs; Chemicals; Infectious agents; Ionizing radiation; Neurobehavioral teratogens; Substances of abuse

Indexed keywords

ALCOHOL; BIPHENYL DERIVATIVE; CARBAMAZEPINE; COCAINE; COUMARIN DERIVATIVE; LEAD; METHYLMERCURY; MISOPROSTOL; PHENYTOIN; PYRIMETHAMINE PLUS SULFADOXINE; RETINOID; THALIDOMIDE; VALPROIC ACID;

ALCOHOL ABUSE; ARTICLE; ATTENTION DEFICIT DISORDER; COCAINE DEPENDENCE; CONGENITAL TOXOPLASMOSIS; CYTOMEGALOVIRUS; DEVELOPMENTAL DISORDER; DISEASE SEVERITY; HUMAN; INTELLIGENCE QUOTIENT; IONIZING RADIATION; MONOTHERAPY; NERVE CELL DIFFERENTIATION; PRENATAL EXPOSURE; PRIORITY JOURNAL; PSYCHOMOTOR DEVELOPMENT; RADIATION EXPOSURE; RUBELLA VIRUS; SUBSTANCE ABUSE; TOXOPLASMA; TOXOPLASMA GONDII; CENTRAL NERVOUS SYSTEM; FEMALE; GROWTH, DEVELOPMENT AND AGING; PREGNANCY; REVIEW;

CENTRAL NERVOUS SYSTEM; DEVELOPMENTAL DISABILITIES; FEMALE; HUMANS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 84875245233     PISSN: 19405510     EISSN: 19405529     Source Type: Journal    
DOI: 10.1002/ddrr.1102     Document Type: Article

References (168)

1. Accornero VH, Anthony JC, Morrow CE, et al. 2011. Estimated effects of in utero cocaine exposure on examiner-rated behavior at age 7 years. Neurotoxicol Teratol 33:370-378.
2. Adab N, Jacoby A, Smith D, et al. 2001. Additional educational needs in children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 70:15-21.
3. Adab N, Kini U, Vinten J, et al. 2004. The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 75:1575-1583.
4. Adams J, Lammer E. 1991. Relationship between dysmorphology and neuropsychological function in children exposed to isotretinoin "in utero". In: Fuji T, Boer GJ, editors. Functional neuroteratology of short term exposure to drugs. Tokyo: Teikyo University Press. p 159-170.
5. Adams J, Lammer EJ. 1993. Neurobehavioral teratology of isotretinoin. Reprod Toxicol 7:175-177.
6. Amin-Zaki L, Elhassani S, Majeed MA, et al. 1976. Perinatal methylmercury poisoning in Iraq. Am J Dis Child 130:1070-1076.
7. Anday EK, Cohen ME, Kelley NE, et al. 1989. Effect of in utero cocaine exposure on startle and its modification. Dev Pharmacol Ther 12:137-145.
8. Aronson M, Hagberg B, Gillberg C. 1997. Attention deficit and autistic spectrum problems in children exposed to alcohol during gestation. Dev Med Child Neurol 39:583-587.
9. Asanbe CB, Lockert E. 2006. Cognitive abilities of African American children with prenatal cocaine/polydrug exposure. J Health Care Poor Underserved 17:400-412.
10. Axelrad DA, Bellinger DC, Ryan LM, et al. 2007. Dose-response relationship of prenatal mercury exposure and IQ: an integrative analysis of epidemiologic data. Environ Health Perspect 115:609-615.
11. Azuma SD, Chasnoff IJ. 1993. Outcome of children prenatally exposed to cocaine and other drugs: a path analysis of three-year data. Pediatrics 92:396-402.
12. Baghurst PA, McMichael AJ, Wigg NR, et al. 1992. Environmental exposure to lead and children's intelligence at the age of seven years. The Port Pirie Cohort Study. N Engl J Med 327:1279-1284.
13. Bandim JM, Ventura LO, Miller MT, et al. 2003. Autism and M€obius sequence: an explanatory study of children in northeastern Brazil. Arq Neuropsiquiatr 61:181-185.
14. Bandstra ES, Morrow CE, Accornero VH, et al. 2011. Estimated effects of in utero cocaine exposure on language development through early adolescence. Neurotoxicol Teratol 33:25-35.
15. Bellinger D, Leviton A, Waternaux C, et al. 1987. Longitudinal analyses of prenatal and postnatal lead exposure and early cognitive development. N Engl J Med 316: 1037-1043.
16. Betancourt LM, Yang W, Brodsky NL, et al. 2011. Adolescents with and without gestational cocaine exposure: longitudinal analysis of inhibitory control, memory and receptive language. Neurotoxicol Teratol 33:36-46.
17. Blot WJ, Miller RW. 1973. Mental retardation following in utero exposure to the atomic bombs of Hiroshima and Nagasaki. Radiology 106:617-619.
18. Boppana SB, Fowler KB, Vaid Y, et al. 1997. Neuroradiographic findings in the newborn period and long-term outcome in children with symptomatic congenital cytomegalovirus infection. Pediatrics 99:409-414.
19. Bosnjak VM, Daković I, Duranović V, et al. 2011. Malformations of cortical development in children with congenital cytomegalovirus infection-a study of nine children with proven congenital cytomegalovirus infection. Coll Antropol 35 (Suppl 1):229-234.
20. Boyd TA, Ernhart CB, Greene TH, et al. 1991. Prenatal alcohol exposure and sustained attention in the preschool years. Neurotoxicol Teratol 13:49-55.
21. Brent RL. 1980. Radiation teratogenesis. Teratology 21:281-298.
22. Bridgett DJ, Mayes LC. 2011. Development of inhibitory control among prenatally cocaine exposed and non-cocaine exposed youths from late childhood to early adolescence: the effects of gender and risk and subsequent aggressive behavior. Neurotoxicol Teratol 33:47-60.
23. Carmody DP, Bennett DS, Lewis M. 2011. The effects of prenatal cocaine exposure and gender on inhibitory control and attention. Neurotoxicol Teratol 33:61-68.
24. Chasnoff IJ, Burns WJ, Schnoll SH, et al. 1985. Cocaine use in pregnancy. N Engl J Med 313:666-669.
25. Chasnoff IJ, Bussey ME, Savich R, et al. 1986. Perinatal cerebral infarction and maternal cocaine use. J Pediatr 108:456-459.
26. Chasnoff IJ, Griffith DR, Freier C, et al. 1992. Cocaine/polydrug use in pregnancy: two-year follow-up. Pediatrics 89:284-289.
27. Chen YC, Guo YL, Hsu CC. 1992a. Cognitive development of children prenatally exposed to polycarbonated biphenyls (Yu-Cheng children) and their siblings. J Formos Med Assoc 91:704-707.
28. Chen YC, Guo YL, Hsu CC, et al. 1992b. Cognitive development of Yu-Cheng ("oil disease") children prenatally exposed to heat degraded PCBs. JAMA 268:3213-3218.
29. Chess S. 1971. Autism in children with congenital rubella. J Autism Child 1:33-47.
30. Chess S, Fernandez P, Korn S. 1978. Behavioral consequences of congenital rubella. J Pediatr 93:699-703.
31. Christianson AL, Chesler N, Kromberg JGR. 1994. Fetal valproate syndrome: clinical and neurodevelopmental features in two sibling pairs. Dev Med Child Neurol 36:361-369.
32. Coles CD, Brown RT, Smith IE, et al. 1991. Effects of prenatal alcohol exposure at school age. I. Physical and cognitive development. Neurotoxicol Teratol 13:357-367.
33. Coles CD, Goldstein FC, Lynch ME, et al. 2011. Memory and brain volume in adults prenatally exposed to alcohol. Brain Cogn 75: 67-77.
34. Coles CD, Kable JA, Taddeo E. 2009. Math performance and behavior problems in children affected by prenatal alcohol exposure: intervention and follow-up. J Dev Behav Pediatr 30:7-15.
35. Coles CD, Smith I, Fernhoff PM, et al. 1985. Neonatal neurobehavioral characteristics as correlates of maternal alcohol use during gestation. Alcohol Clin Exp Res 9:454-460.
36. Conboy TJ, Pass RF, Stagno S, et al. 1987. Early clinical manifestations, and intellectual outcome in children with symptomatic congenital cytomegalovirus infection. J Pediatr 111:343-348.
37. Cooper LZ, Ziring PR, Ockerse AB, et al. 1969. Rubella. Clinical manifestations and management. Am J Dis Child 118:18-29.
38. Couvreur J, Desmonts G. 1962. Congenital and maternal toxoplasmosis: a review of 300 congenital cases. Dev Med Child Neurol 4:519-530.
39. Cox C, Breazna A, Davidson PW, et al. 1999. Prenatal and postnatal methylmercury exposure and neurodevelopmental outcomes [Letter]. JAMA 282:1333-1334.
40. Cummings C, Stewart M, Stevenson M, et al. 2011. Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine. Arch Dis Child 96:643-647.
41. Daniels JL, Longnecker MP, Klebanoff MA, et al. 2003. Prenatal exposure to low-level polychlorinated biphenyls in relation to mental and motor development at 8 months. Am J Epidemiol 157:485-492.
42. Davidson PW, Myers GJ, Cox C, et al. 1998. Effects of prenatal and postnatal methylmercury exposure from fish consumption on neurodevelopment: outcomes at 66 months of age in the Seychelles Child Development Study. JAMA 280:701-707.
43. Dean JCS, Hailey H, Moore SJ, et al. 2002. Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth. J Med Genet 39:251-259.
44. Dekaban AS. 1968. Abnormalities in children exposed to X-irradiation during various stages of gestation: tentative timetable of radiation injury to the human fetus. J Nuclear Med 9:471-477.
45. Delaney-Black V, Covington C, Templin T, et al. 2000a. Expressive language development of children exposed to cocaine prenatally: literature review and report of a prospective cohort study. J Commun Disord 33:463-480.
46. Delaney-Black V, Covington C, Templin T, et al. 2000b. Teacher-assessed behavior of children prenatally exposed to cocaine. Pediatrics 106:782-791.
47. Desmond MM, Wilson GS, Melnick JL, et al. 1967. Congenital rubella encephalitis. Course and early sequelae. J Pediatr 71:311-331.
48. Dietrich KN, Berger OG, Succop PA, et al. 1993. The developmental consequences of low to moderate prenatal and postnatal lead exposure: intellectual attainment in the Cincinnati Lead Study Cohort following school entry. Neurotoxicol Teratol 15:37-44.
49. Dietrich KN, Krafft KM, Bornschein RL, et al. 1987. Low-level lead exposure effect on neurobehavioral development in early infancy. Pediatrics 80:721-730.
50. Dixon SD, Bejar R. 1989. Echoencephalographic findings in neonates associated with maternal cocaine and methamphetamine use: incidence and clinical correlates. J Pediatr 115:770-778.
51. Doberczak TM, Shanzer S, Senie RT, et al. 1988. Neonatal neurologic and electroencephalographic effects of intrauterine cocaine exposure. J Pediatr 113:354-358.
52. Dunn K, Yoshimaru H, Otake M, et al. 1990. Prenatal exposure to ionizing radiation and subsequent development of seizures. Am J Epidemiol 131:114-123.
53. Engman ML, Lewensohn-Fuchs I, Mosskin M, et al. 2010. Congenital cytomegalovirus infection: the impact of cerebral cortical malformations. Acta Paediatr 99:1344-1349.
54. Eriksson K, Viinikainen K, M€onkk€onen A, et al. 2005. Children exposed to valproate in utero-population based evaluation of risks and confounding factors for long-term neurocognitive development. Epilepsy Res 65:189-200.
55. Funatsu I, Yamashita F, Ito Y, et al. 1972. Polychlorbiphenyls (PCB) induced fetopathy. I. Clinical observation. Kurume Med J 19:43- 51.
56. Gaily E, Kantola-Sorsa E, Granstr€om ML. 1988. Intelligence of children of epileptic mothers. J Pediatr 113:677-684.
57. Gaily E, Kantola-Sorsa E, Hiilesmaa V, et al. 2004. Normal intelligence in children with prenatal exposure to carbamazepine. Neurology 62:28-32.
58. Goldschmidt L, Richardson GA, Stoffer DS, et al. 1996. Prenatal alcohol exposure and academic achievement at age six: a nonlinear fit. Alcohol Clin Exp Res 20:763-770.
59. Goldstein L, Murphy DP. 1929a. Etiology of ill health in children born after maternal pelvic irradiation. II. Defective children born after postconceptional maternal irradiation. Am J Roentgenol 22:322-331.
60. Goldstein L, Murphy DP. 1929b. Microcephalic idiocy following radium therapy for uterine cancer during pregnancy. Am J Obstet Gynecol 18:189-195, 281-283.
61. Gotfryd K, Hansen M, Kawa A, et al. 2011. The teratogenic potencies of valproic acid derivatives and their effects on biological endpoints are related to changes in histone deacetylase and Erk1/2 activities. Basic Clin Pharmacol Toxicol 109:164-174.
62. Grandjean P, Budtz-Jrgensen E, White RF, et al. 1999. Methylmercury exposure biomarkers as indicators of neurotoxicity in children aged 7 years. Am J Epidemiol 150:301-305.
63. Grandjean P, Weihe P, White RF, et al. 1997. Cognitive deficit in 7-year-old children with prenatal exposure to methylmercury. Neurotoxicol Teratol 19:417-428.
64. Gray KA, Klebanoff MA, Brock JW, et al. 2005. In utero exposure to background levels of polychlorinated biphenyls and cognitive functioning among school-aged children. Am J Epidemiol 162:17-26.
65. Greenbaum R, Nulman I, Rovet J, et al. 2002. The Toronto experience in diagnosing alcohol- related neurodevelopmental disorder: a unique profile of deficits and assets. Can J Clin Pharmacol 9:215-225.
66. Hall JG, Pauli RM, Wilson KM. 1980. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 68:122-140.
67. Hanshaw JB, Scheiner AP, Moxley AW, et al. 1976. School failure and deafness after "silent" congenital cytomegalovirus infection. N Engl J Med 295:468-470.
68. Hanson JW, Myrianthopoulos NC, Harvey MA, et al. 1976. Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome. J Pediatr 89:662-668.
69. Harada M. 1976. Intrauterine poisoning: clinical and epidemiological studies and significance of the problem. Bull Inst Constit Med Kumamoto Univ 25 (SUPPL):38-50.
70. Hill SY, Lowers L, Locke-Wellman J, et al. 2000. Maternal smoking and drinking during pregnancy and the risk for child and adolescent psychiatric disorders. J Stud Alcohol 61:661-668.
71. Howell KK, Lynch ME, Platzman KA, et al. 2006. Prenatal alcohol exposure and ability, academic achievement, and school functioning in adolescence: a longitudinal follow-up. J Pediatr Psychol 31:116-126.
72. Hoyme HE, Jones KL, Dixon SD, et al. 1990. Prenatal cocaine exposure and fetal vascular disruption. Pediatrics 85:743-747.
73. Hume RF Jr, O'Donnell KJ, Stanger CL, et al. 1989. In utero cocaine exposure: observations of fetal behavioral state may predict neonatal outcome. Am J Obstet Gynecol 161:685-690.
74. Hurt H, Malmud E, Betancourt L, et al. 1997. Children with in utero cocaine exposure do not differ from control subjects on intelligence testing. Arch Pediatr Adolesc Med 151:1237-1241.
75. International Commission on Radiological Protection. 1986. Developmental effects of irradiation on the brain of the embryo and fetus. Ann ICRP 16:1-43.
76. Isenberg SJ, Spierer A, Inkelis SH. 1987. Ocular signs of cocaine intoxication in neonates. Am J Ophthalmol 103:211-214.
77. Ivarsson SA, Bjerre I, Vegfors P, et al. 1990. Autism as one of several disabilities in two children with congenital cytomegalovirus infection. Neuropediatrics 21:102-103.
78. Ivarsson SA, Lernmark B, Svanberg L. 1997. Ten-year clinical, developmental, and intellectual follow-up of children with congenital cytomegalovirus infection without neurologic symptoms at one year of age. Pediatrics 99:800-803.
79. Jacobson JL, Jacobson SW. 2002. Association of prenatal exposure to an environmental contaminant with intellectual function in childhood. J Toxicol Clin Toxicol 40:467-475.
80. Jedrychowski W, Jankowski J, Flak E, et al. 2006. Effects of prenatal exposure to mercury on cognitive and psychomotor function in oneyear- old infants: epidemiologic cohort study in Poland. Ann Epidemiol 16:439-447.
81. Jedrychowski W, Perera F, Jankowski J, et al. 2008. Prenatal low-level lead exposure and developmental delay of infants at age 6 months (Krakow inner city study). Int J Hyg Environ Health 211:345-351.
82. Jones KL, Lacro RV, Johnson KA, et al. 1989. Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med 320:1661-1666.
83. Jones KL, Smith DW. 1973. Recognition of the fetal alcohol syndrome in early infancy. Lancet 2:999-1001.
84. Jones KL, Smith DW, Ulleland CN, et al. 1973. Pattern of malformation in offspring of chronic alcoholic mothers. Lancet 1:1267-1271.
85. Kawatani M, Nakai A, Okuno T, et al. 2010. Detection of cytomegalovirus in preserved umbilical cord from a boy with autistic disorder. Pediatr Int 52:304-307.
86. Kini U, Adab N, Vinten J, et al.; Liverpool and Manchester Neurodevelopmental Study Group. 2006. Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes. Arch Dis Child Fetal Neonatal Ed 91:F90-F95.
87. Knopnik VS, Heath AC, Jacob T, et al. 2006. Maternal alcohol use disorder and offspring ADHD: disentangling genetic and environmental effects using a children-of-twins design. Psychol Med 36:1461-1471.
88. Koppe JG, Loewer-Sieger DH, deRoever-Bonnet H. 1986. Results of 20-year follow-up of congenital toxoplasmosis. Lancet 1:254-256. Koren G, Schuler L. 2001. Taking drugs during pregnancy. How safe are the unsafe? Can Fam Physician 47:951-953.
89. Kumar ML, Nankervis GA, Gold E. 1973. Inapparent congenital cytomegalovirus infection. A follow-up study. N Engl J Med 288:1370-1372.
90. Kumar ML, Nankervis GA, Jacobs IB, et al. 1984. Congenital and postnatally acquired cytomegalovirus infections: long-term follow- up. J Pediatr 104:674-679.
91. Lemoine P, Harousseau H, Borteyru JP, et al. 1968. Les enfants des parents alcoholiques: anomalies observees a propos de 127 cas [French] (The children of alcoholic parents: anomalies observed in 127 cases). Quest Med 25:476-482.
92. Levine TP, Lester B, Lagasse L, et al. 2012. Psychopathology and special education enrollment in children with prenatal cocaine exposure. J Dev Behav Pediatr 33:377-386.
93. Mansoor E, Morrow CE, Accornero VH, et al. 2012. Longitudinal effects of prenatal cocaine use on mother-child interactions at ages 3 and 5 years. J Dev Behav Pediatr 33:32-41.
94. Markowitz PI. 1983. Autism in a child with congenital cytomegalovirus infection. J Autism Dev Disord 13:249-253.
95. Marsh DO, Myers GJ, Clarkson TW, et al. 1980. Fetal methylmercury poisoning: clinical and toxicological data on 29 cases. Ann Neurol 7:348-353.
96. Matsumoto H, Koya G, Takeuchi T. 1965. Fetal Minamata disease. A neuropathological study of intrauterine intoxication by a methyl mercury compound. J Neuropathol Exp Neurol 24:563-574.
97. Mattson SN, Riley EP, Gramling L, et al. 1997. Heavy prenatal alcohol exposure with or without physical features of fetal alcohol syndrome leads to IQ deficits. J Pediatr 131:718-721.
98. Mawer G, Clayton-Smith J, Coyle H, et al. 2002. Outcome of pregnancy in women attending an outpatient epilepsy clinic: adverse features associated with higher doses of sodium valproate. Seizure 11:512-518.
99. McLeod R, Boyer K, Karrison T, et al.; Toxoplasmosis Study Group. 2006. Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago- Based, Congenital Toxoplasmosis Study. Clin Infect Dis 42:1383-1394.
100. Meador KJ, Baker GA, Browning N, et al.; for the NEAD Study Group. 2009. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med 360:1597-1605.
101. Meador KJ, Baker GA, Browning N, et al.; for the NEAD Study Group. 2011. Foetal antiepileptic drug exposure and verbal and nonverbal abilities at three years of age. Brain 134:396-404.
102. Mick E, Biederman J, Faraone SV, et al. 2002. Case-control study of attention-deficit hyperactivity disorder and maternal smoking, alcohol use, and drug use during pregnancy. J Am Acad Child Adolesc Psychiatry 41:378-385.
103. Miller RW. 1956. Delayed effects occurring within the first decade after exposure of young individuals to the Hiroshima atomic bomb. Pediatrics 18:1-17.
104. Miller RW, Mulvihill JJ. 1976. Small head size after atomic irradiation. Teratology 14:355-358.
105. Moore KL, Persaud TVN. 2003. The developing human: clinically oriented embryology, 7th ed. Philadelphia, PA: Saunders. p 158:461.
106. Moore SJ, Turnpenny P, Quinn A, et al. 2000. A clinical study of 57 children with fetal anticonvulsant syndromes. J Med Genet 37:489-497.
107. Murakami U. 1972. The effect of organic mercury on intrauterine life. Adv Exp Med Biol 27:301-336.
108. Myers GJ, Davidson PW, Cox C, et al. 2003. Prenatal mercury exposure from ocean fish consumption in the Seychelles child development study. Lancet 361:1686-1692.
109. Nanson JL. 1992. Autism in fetal alcohol syndrome: a report of six cases. Alcohol Clin Exp Res 16:558-565.
110. Newman CG. 1985. Teratogen update: clinical aspects of thalidomide embryopathy-a continuing preoccupation. Teratology 32: 133-144.
111. Noyola DE, Demmler GJ, Nelson CT, et al.; Houston Congenital CMV Longitudinal Study Group. 2001. Early predictors of neurodevelopmental outcome in symptomatic congenital cytomegalovirus infection. J Pediatr 138:325-331.
112. Noyola DE, Demmler GJ, Williamson WD, et al. 2000. Cytomegalovirus urinary excretion and long term outcome in children with congenital cytomegalovirus infection. Congenital CMV Longitudinal Study Group. Pediatr Infect Dis J 19:505-510.
113. Nulman I, Rovet J, Altmann D, et al. 1994. Neurodevelopment of adopted children exposed in utero to cocaine. CMAJ 151:1591-1597.
114. Nulman I, Rovet J, Greenbaum R, et al. 2001. Neurodevelopment of adopted children exposed in utero to cocaine: the Toronto Adoption Study. Clin Invest Med 24: 129-137.
115. Olariu TR, Remington JS, McLeod R, et al. 2011. Severe congenital toxoplasmosis in the United States clinical and serologic findings in untreated infants. Pediatr Infect Dis J 30:1056-1061.
116. Oloffson M, Buckley W, Andersen GE, et al. 1983. Investigation of 89 children born by drug dependent mothers. II. Follow-up 1- 10 years after birth. Acta Paediatr Scand 72:407-410.
117. Ornoy A. 2003. The impact of intrauterine exposure versus postnatal environment in neurodevelopmental toxicity: long-term neurobehavioral studies in children at risk for developmental disorders. Toxicol Lett 140/ 141:171-181.
118. Ornoy A, Cohen E. 1996. Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy. Arch Dis Child 75:517-520.
119. Ornoy A, Daka L, Goldzweig G, et al. 2010. Neurodevelopmental and psychological assessment of adolescents born to drug-addicted parents: effects of SES and adoption. Child Abuse Negl 34:354-368.
120. Ornoy A, Michailevskaya V, Lukashov I, et al. 1996. The developmental outcome of children born to heroin-dependent mothers, raised at home or adopted. Child Abuse Negl 20:385-396.
121. Ornoy A, Segal J, Bar-Hamburger R, et al. 2001. Developmental outcome of school-age children born to mothers with heroin dependency: importance of environmental factors. Dev Med Child Neurol 43:668-675.
122. Otake M, Schull WJ. 1984. In utero exposure to A-bomb radiation and mental retardation; a reassessment. Br J Radiol 57:409-414.
123. Otake M, Schull WJ, Lee S. 1996. Threshold for radiation-related severe mental retardation in prenatally exposed A-bomb survivors: a reanalysis. Int J Radiat Biol 70:755-763.
124. Otake M, Schull WJ, Yoshimaru H. 1991. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Brain damage among the prenatally exposed. J Radiat Res (Tokyo) 32 (SUPPL):249-264.
125. Pass RF, Stagno S, Myers GJ, et al. 1980. Outcome of symptomatic congenital cytomegalovirus infection: results of long-term longitudinal follow-up. Pediatrics 66:758-762.
126. Pastuszak AL, Sch€uler L, Speck-Martins CE, et al. 1998. Use of misoprostol during pregnancy and M€obius' syndrome in infants. N Engl J Med 338:1881-1885.
127. Phiel CJ, Zhang F, Huang EY, et al. 2001. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 276:36734-36741.
128. Plummer GW. 1952. Anomalies occurring in children exposed in utero to the atomic bomb in Hiroshima. Pediatrics 10:687-692.
129. Potter SM, Zelazo PR, Stack DM, et al. 2000. Adverse effects of fetal cocaine exposure on neonatal auditory information processing. Pediatrics 105:e40.
130. Rasalam AD, Hailey H, Williams JH, et al. 2005. Characteristics of fetal anticonvulsant syndrome associated autistic disorder. Dev Med Child Neurol 47:551-555.
131. Reynolds DW, Stagno S, Stubbs KG, et al. 1974. Inapparent congenital cytomegalovirus infection with elevated cord IgM levels. Causal relation with auditory and mental deficiency. N Engl J Med 290:291-296.
132. Rodning C, Beckwith L, Howard J. 1989. Prenatal exposure to drugs: behavioral distortions reflecting CNS impairment? Neurotoxicology 10:629-634.
133. Roizen N, Swisher CN, Stein MA, et al. 1995. Neurologic and developmental outcome in treated congenital toxoplasmosis. Pediatrics 95:11-20.
134. Rorke LB. 1973. Nervous system lesions in the congenital rubella syndrome. Arch Otolaryngol 98:249-251.
135. R€oser D, Nielsen HV, Petersen E, et al. 2010. Congenital toxoplasmosis-a report on the Danish neonatal screening programme 1999- 2007. J Inherit Metab Dis 33:s241-s247.
136. Sáfadi MA, Berezin EN, Farhat CK, et al. 2003. Clinical presentation and follow up of children with congenital toxoplasmosis in Brazil. Braz J Infect Dis 7:325-331.
137. Saxon SA, Knight W, Reynolds DW, et al. 1973. Intellectual deficits in children born with subclinical congenital toxoplasmosis: a preliminary report. J Pediatr 82:792-799.
138. Scolnik D, Nulman I, Rovet J, et al. 1994. Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy. JAMA 271:767-770.
139. Shapiro S, Hartz SC, Siskind V, et al. 1976. Anticonvulsants and parental epilepsy in the development of birth defects. Lancet 1:272-275.
140. Shih L, Cone-Wesson B, Reddix B. 1988. Effects of maternal cocaine abuse on neonatal auditory system. Int J Pediatr Otorhinolaryngol 15:245-251.
141. Singer LT, Minnes S, Short E, et al. 2004. Cognitive outcomes of preschool children with prenatal cocaine exposure. JAMA 291: 2448-2456.
142. Snyder RD. 1971. Congenital mercury poisoning. N Engl J Med 284:1014-1016.
143. Starr GJ, Bart RD Jr, Gold E. 1970. Inapparent congenital cytomegalovirus infection. Clinical and epidemiologic characteristics in early infancy. N Engl J Med 282:1075-1078.
144. Steuerwald U, Weihe P, Jrgensen PJ, et al. 2000. Maternal seafood diet, methylmercury exposure, and neonatal neurologic function. J Pediatr 136:599-605.
145. Stewart PW, Lonky E, Reihman J, et al. 2008. The relationship between prenatal PCB exposure and intelligence (IQ) in 9-year-old children. Environ Health Perspect 116:1416-1422.
146. Streissguth AP, Barr HM, Sampson PD. 1990. Moderate prenatal alcohol exposure: effects on child IQ and learning problems at age 7 1/ 2 years. Alcohol Clin Exp Res 14:662-669.
147. Streissguth AP, Barr HM, Sampson PD, et al. 1986. Attention, distraction and reaction time at age 7 years and prenatal alcohol exposure. Neurobehav Toxicol Teratol 8:717-725.
148. Str€omland K, Nordin V, Miller M, et al. 1994. Autism in thalidomide embryopathy: a population study. Dev Med Child Neurol 36:351-356.
149. Sweeten TL, Posey DJ, McDougle CJ. 2004. Brief report: autistic disorder in three children with cytomegalovirus infection. J Autism Dev Disord 34:583-586.
150. Temple RO, Pass RF, Boll TJ. 2000. Neuropsychological functioning in patients with asymptomatic congenital cytomegalovirus infection. J Dev Behav Pediatr 21:417-422.
151. Tenorio GM, Nazvi M, Bickers GH, et al. 1988. Intrauterine stroke and maternal polydrug abuse. Case report. Clin Pediatr (Phila) 27:565-567.
152. Ulleland CN. 1972. The offspring of alcoholic mothers. Ann N Y Acad Sci 197:167-169.
153. Vanoverloop D, Schnell RR, Harvey EA, et al. 1992. The effects of prenatal exposure to phenytoin and other anticonvulsants on intellectual function at 4 to 8 years of age. Neurotoxicol Teratol 14:329-335.
154. Villena I, Ancelle T, Delmas C, et al.; Toxosurv Network and National Reference Centre for Toxoplasmosis. 2010. Congenital toxoplasmosis in France in 2007: first results from a national surveillance system. Euro Suveill 15:pii 19600.
155. Walkowiak J, Wiener JA, Fastabend A, et al. 2001. Environmental exposure to polychlorinated biphenyls and quality of the home environment: effects on psychodevelopment in early childhood. Lancet 258:1602-1607.
156. Wide K, Henning E, Thomson T, et al. 2002. Psychomotor development in preschool children exposed to antiepileptic drugs in utero. Acta Paediatr 91:409-414.
157. Wide K, Winbladh B, Thomson T, et al. 2000. Psychomotor development and minor anomalies in children exposed to antiepileptic drugs in utero: a prospective populationbased study. Dev Med Child Neurol 42:87- 92.
158. Williams G, King J, Cunnigham M, et al. 2001. Fetal valproate syndrome and autism: additional evidence of an association. Dev Med Child Neurol 43:202-206.
159. Williams PG, Hersh JH. 1997. A male with fetal valproate syndrome and autism. Dev Med Child Neurol 39:632-634.
160. Williamson WD, Desmond MM, LaFevers N, et al. 1982. Symptomatic congenital cytomegalovirus. Disorders of language, learning, and hearing. Am J Dis Child 136: 902-905.
161. Wilson CB, Remington JS, Stagno S, et al. 1980. Development of adverse sequelae in children born with subclinical congenital toxoplasma infection. Pediatrics 66:767-774.
162. Woo SY, Fuller LM, Cundiff JH, et al. 1992. Radiotherapy during pregnancy for clinical stages IA-IIA Hodgkin's disease. Int J Radiat Oncol Biol Phys 23:407-412.
163. Wood JW, Johnson KG, Omori Y. 1967a. In utero exposure to the Hiroshima atomic bomb. An evaluation of head size and mental retardation: twenty years later. Pediatrics 39:385-392.
164. Wood JW, Johnson KG, Omori Y, et al. 1967b. Mental retardation in children exposed in utero to the atomic bombs in Hiroshima and Nagasaki. Am J Public Health 57:1381-1389.
165. Yoshimaru H, Otake M, Fujikoshi Y, et al. 1991. Effect on school performance of prenatal exposure to the Hiroshima atomic bomb [Japanese]. Nihon Eiseigaku Zasshi 46:747-754.
166. Yoshimaru H, Otake M, Schull WJ, et al. 1995. Further observations on abnormal brain development caused by prenatal A-bomb exposure to ionizing radiation. Int J Radiat Biol 67:359-371.
167. Zhang XW, Li F, Yu XW, et al. 2007. Physical and intellectual development in children with asymptomatic congenital cytomegalovirus infection: a longitudinal cohort study in Qinba mountain area, China. J Clin Virol 40:180-185.
168. Zuckerman B, Frank DA, Hingson R, et al. 1989. Effects of maternal marijuana and cocaine use on fetal growth. N Engl J Med 320:762-768.